As of 2025-07-12, the EV/EBITDA ratio of Deciphera Pharmaceuticals Inc (DCPH) is -10.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DCPH's latest enterprise value is 2,121.80 mil USD. DCPH's TTM EBITDA according to its financial statements is -204.61 mil USD. Dividing these 2 quantities gives us the above DCPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 13.6x | 13.3x |
| Forward P/E multiples | 15.6x - 28.2x | 20.5x |
| Fair Price | (35.81) - (31.12) | (38.93) |
| Upside | -239.9% - -221.6% | -252.1% |
| Date | EV/EBITDA |